The deal range was $8.25-$8.50. Jefferies, Leerink and Wells Fargo acted as joint book running managers for the offering.
Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ENGN:
- enGene Holdings Prices $130 Million Public Offering to Advance Genetic Medicine Programs
- enGene Holdings Announces Public Offering of Common Shares
- enGene announves common shares offering, no amount given
- enGene price target raised to $19 from $18 at Morgan Stanley
- enGene price target raised to $33 from $30 at Oppenheimer